# BCP Investment Corp: financial statements, quarterly

BCIC · Nasdaq · CIK 1372807 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bcic.md) · [Financials](/companies/bcic/financials.md) · [Filings](/companies/bcic/filings.md) · [Insiders](/companies/bcic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bcic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net income | $m | [7.4](/filings/0000950170-25-038754.md) | [7.0](/filings/0000950170-25-038754.md) | [4.5](/filings/0000950170-25-066919.md) | [(6.4)](/filings/0000950170-25-104992.md) | [(1.5)](/filings/0001193125-25-269482.md) | [(2.5)](/filings/0000950170-25-038754.md) | [(0.1)](/filings/0001193125-26-211878.md) | [(4.5)](/filings/0001193125-26-337959.md) | [23.6](/filings/0001193125-25-269482.md) | [(7.5) d](/filings/0001193125-26-093918.md) | [(10.2)](/filings/0001193125-26-211878.md) | [(9.9)](/filings/0001193125-26-337959.md) |
| Diluted EPS | $ per share | [0.78](/filings/0000950170-25-038754.md) | [0.74](/filings/0000950170-25-038754.md) | [0.48](/filings/0000950170-25-066919.md) | [(0.69)](/filings/0000950170-25-104992.md) | [(0.16)](/filings/0001193125-25-269482.md) | [(0.28)](/filings/0000950170-25-038754.md) | [(0.01)](/filings/0001193125-26-211878.md) | [(0.49)](/filings/0001193125-26-337959.md) | [1.86](/filings/0001193125-25-269482.md) | not reported | [(0.82)](/filings/0001193125-26-211878.md) | [(0.80)](/filings/0001193125-26-337959.md) |
| Basic EPS | $ per share | [0.78](/filings/0000950170-25-038754.md) | [0.74](/filings/0000950170-25-038754.md) | [0.48](/filings/0000950170-25-066919.md) | [(0.69)](/filings/0000950170-25-104992.md) | [(0.16)](/filings/0001193125-25-269482.md) | [(0.28)](/filings/0000950170-25-038754.md) | [(0.01)](/filings/0001193125-26-211878.md) | [(0.49)](/filings/0001193125-26-337959.md) | [1.88](/filings/0001193125-25-269482.md) | not reported | [(0.82)](/filings/0001193125-26-211878.md) | [(0.80)](/filings/0001193125-26-337959.md) |

- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.9](/filings/0000950170-24-123269.md) | [26.9](/filings/0001193125-26-093918.md) | [20.8](/filings/0000950170-25-066919.md) | [9.8](/filings/0000950170-25-104992.md) | [13.7](/filings/0001193125-25-269482.md) | [17.5](/filings/0001193125-26-093918.md) | [9.2](/filings/0001193125-26-211878.md) | [11.2](/filings/0001193125-26-337959.md) | [2.8](/filings/0001193125-25-269482.md) | [3.7](/filings/0001193125-26-337959.md) | [51.8](/filings/0001193125-26-211878.md) | [2.5](/filings/0001193125-26-337959.md) |
| Total assets | $m | [546](/filings/0000950170-23-061092.md) | [549](/filings/0000950170-25-038754.md) | [527](/filings/0000950170-24-055625.md) | [489](/filings/0000950170-24-093894.md) | [464](/filings/0000950170-24-123269.md) | [454](/filings/0001193125-26-093918.md) | [439](/filings/0000950170-25-066919.md) | [428](/filings/0000950170-25-104992.md) | [568](/filings/0001193125-25-269482.md) | [524](/filings/0001193125-26-337959.md) | [544](/filings/0001193125-26-211878.md) | [469](/filings/0001193125-26-337959.md) |
| Total liabilities | $m | [331](/filings/0000950170-23-061092.md) | [336](/filings/0000950170-25-038754.md) | [317](/filings/0000950170-24-055625.md) | [292](/filings/0000950170-24-093894.md) | [276](/filings/0000950170-24-123269.md) | [275](/filings/0001193125-26-093918.md) | [265](/filings/0000950170-25-066919.md) | [263](/filings/0000950170-25-104992.md) | [337](/filings/0001193125-25-269482.md) | [314](/filings/0001193125-26-337959.md) | [351](/filings/0001193125-26-211878.md) | [290](/filings/0001193125-26-337959.md) |
| Long-term debt | $m | [318](/filings/0000950170-23-061092.md) | [322](/filings/0000950170-25-038754.md) | [289](/filings/0000950170-24-055625.md) | [283](/filings/0000950170-24-093894.md) | [265](/filings/0000950170-24-123269.md) | [265](/filings/0001193125-26-093918.md) | [253](/filings/0000950170-25-066919.md) | [254](/filings/0000950170-25-104992.md) | [322](/filings/0001193125-25-269482.md) | [307](/filings/0001193125-26-337959.md) | [336](/filings/0001193125-26-211878.md) | [281](/filings/0001193125-26-337959.md) |
| Shareholders' equity | $m | [215](/filings/0000950170-24-123269.md) | [214](/filings/0001193125-26-093918.md) | [211](/filings/0001193125-26-093918.md) | [196](/filings/0001193125-26-093918.md) | [188](/filings/0001193125-26-093918.md) | [178](/filings/0001193125-26-337959.md) | [174](/filings/0001193125-26-337959.md) | [165](/filings/0001193125-26-337959.md) | [231](/filings/0001193125-26-093918.md) | [209](/filings/0001193125-26-337959.md) | [193](/filings/0001193125-26-337959.md) | [179](/filings/0001193125-26-337959.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [18.1 d](/filings/0000950170-24-123269.md) | [41.9 d](/filings/0001193125-26-093918.md) | [9.4](/filings/0000950170-25-066919.md) | [11.5 d](/filings/0000950170-25-104992.md) | [15.5 d](/filings/0001193125-25-269482.md) | [20.2 d](/filings/0001193125-26-093918.md) | [0.6](/filings/0001193125-26-211878.md) | [5.3 d](/filings/0001193125-26-337959.md) | [35.4 d](/filings/0001193125-25-269482.md) | [25.3 d](/filings/0001193125-26-093918.md) | [21.6](/filings/0001193125-26-211878.md) | [10.7 d](/filings/0001193125-26-337959.md) |
| Dividends paid | $m | [6.5 d](/filings/0000950170-24-123269.md) | [6.4 d](/filings/0001193125-26-093918.md) | [0.0](/filings/0000950170-25-066919.md) | [12.7 d](/filings/0000950170-25-104992.md) | [6.3 d](/filings/0001193125-25-269482.md) | [6.3 d](/filings/0001193125-26-093918.md) | [4.9](/filings/0001193125-26-211878.md) | [4.3 d](/filings/0001193125-26-337959.md) | [6.4 d](/filings/0001193125-25-269482.md) | [6.1 d](/filings/0001193125-26-093918.md) | [3.9](/filings/0001193125-26-211878.md) | [3.7 d](/filings/0001193125-26-337959.md) |
| Share repurchases | $m | [1.2 d](/filings/0000950170-24-123269.md) | [1.8 d](/filings/0001193125-26-093918.md) | [1.0](/filings/0000950170-25-066919.md) | [1.6 d](/filings/0000950170-25-104992.md) | [0.6 d](/filings/0001193125-25-269482.md) | [0.7 d](/filings/0001193125-26-093918.md) | [0.0](/filings/0001193125-26-211878.md) | [0.0 d](/filings/0000950170-25-104992.md) | [0.3 d](/filings/0001193125-25-269482.md) | [9.0 d](/filings/0001193125-26-093918.md) | [2.1](/filings/0001193125-26-211878.md) | [0.0 d](/filings/0001193125-26-337959.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [9.6](/filings/0000950170-23-061092.md) | [9.6](/filings/0000950170-24-055625.md) | [9.5](/filings/0000950170-24-093894.md) | [9.5](/filings/0000950170-24-123269.md) | [9.3](/filings/0000950170-25-066919.md) | [9.3](/filings/0000950170-25-104992.md) | [9.2](/filings/0001193125-25-269482.md) | [9.2](/filings/0001193125-26-211878.md) | [9.2](/filings/0001193125-26-337959.md) | [12.7](/filings/0001193125-25-269482.md) | [12.4](/filings/0001193125-26-211878.md) | [12.4](/filings/0001193125-26-337959.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,383,652 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-337959.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.